Rapex

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Rapid Alert System for Dangerous Non-food Products

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

RAPEX is the acronym for "Rapid Alert System for Dangerous Non-food Products", a database maintained and published weekly by the European Commission as a rapid alert system for consumers on dangerous consumer products (including cosmetics causing undesirable side effects).

RAPEX is used to exchange information from Member States on dangerous or potentially dangerous consumer products (excluding food and pharmaceutical products and medicines). These include products such as clothing, shoes, cosmetics, jewellery or children's toys with components or properties that are harmful to health, or products with technical defects.

RAPEX enables rapid EU-wide exchange of information on measures such as recall or withdrawal operations, whether they are measures taken by national authorities or voluntary measures by producers and distributors. To monitor the measures, appropriate delivery lists are sent throughout Europe to the locally and factually responsible authorities, such as the food control authorities.

The basis for the establishment of RAPEX is the Product Safety Directive 2001/95/EC (GPSD), an EC Directive on general product safety, which came into force on 15 January 2004.

The European Commission's Directorate-General for Health and Consumers publishes a weekly report on current RAPEX alerts.

The RAPEX database is thus an important source of information on cosmetics that pose a risk to health in the EU member states. Knowledge of this data is of great importance for dermatological advice to patients regarding the use of cosmetics.

General informationThis section has been translated automatically.

In the period 2005-2017, 157 dangerous cosmetic products were reported to the RAPEX database (P. Elser et al 2017). The most frequently reported products were:

  • Bleaching and whitening products (24.2%): Hazardous ingredients were: hydroquinone, kojic acid, mercury, clobetasol, betamethasone
  • Creams/lotions/gels (10.8%) Sources of danger were the ingredients with excessive concentrations of formaldehyde, 5-chloro-2-methyl-isothiazol-3(2H9-one and 2-methyl-isothiazol-3(2H)-one.
  • Nail adhesives (8.9%): Sources of danger were the ingredients methyl methacrylate
  • Henna dyes (11.7%): Sources of danger were the ingredients p-phenyldiamine (up to 10.9%); phenol, N-nitrosodiethanolamine. The latter is classified as human carcinoma.
  • Shower Bath Gel
  • Hair conditioning agents
  • Hair dyes
  • Makeups
  • Shampoos
  • Some products contained unauthorised dyes.
  • One eyelash mascara (eye-lash-extensions) contained the synthetic prostamide F2alpha analogue Bimatoprost (pharmaceutical approved for the treatment of open angle glaucoma).
  • Powder preparations with very small particle size can cause health problems when inhaled, especially by children.

LiteratureThis section has been translated automatically.

  1. Elsner P et al (2017) Dangerous cosmetic product in Germany. Dermatologist 68: 885-889
  2. Rapid Alert System Weekly Nortification Rports: https://ec.europa.eu/consumers/consumers_safety/safety_products/rapex/alerts/?event=main.listNotifications
  3. eur-lex.europa: http://eur-lex.europa.eu/legal content/DE/TXT/?uri=celex%3A32010D0015

Authors

Last updated on: 29.10.2020